Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07038941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Male Pattern of Hair Loss, Androgenic Alopecia
Androgenetic Alopecia (AGA)

Interventions

DRUG: CG2001
DRUG: Placebo foam

Sponsor

Beijing Dayspring Pharmaceutical Technology Co., Ltd